IDYA(IDEAYA Biosciences, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $27.94M | $50.93M | $23.39M | $7.00M | $218.71M |
| 毛利润 | — | — | — | — | — |
| 营业利润 | −$50.27M | −$62.50M | −$134.43M | −$326.98M | −$159.31M |
| 净利润 | −$49.76M | −$58.66M | −$112.96M | −$274.48M | −$113.70M |
| 经营现金流 | −$55.78M | −$87.17M | −$115.22M | −$247.58M | −$71.10M |
| 自由现金流 | −$58.42M | −$90.62M | −$117.59M | −$251.44M | −$73.47M |
| 摊薄每股收益 | $-1.41 | $-1.42 | $-1.96 | $-3.36 | $-1.28 |